Carolyn Palmer
Family · Louisville, KYNPI 1013565829
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,717 of the $6,538 with a category attached, or 87.4%. It is spread thinly across 18 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,013 and has fallen 52.8% since, to $1,422 in 2025. Among family clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $30.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Myriad Genetic Laboratories, Inc.$1K
- Merck$966
- GSK$872
- Genmab U.S., Inc.$848
- AbbVie$564
- plus $1K from 12 others
What the payments were for
- Consulting fees$65010%
- Food & beverage$5,71787%
- Education$1713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $1,049 |
| Myriad Genetic Laboratories, Inc. | 37 | $1,027 |
| Merck | 47 | $966 |
| GSK | 7 | $872 |
| Genmab U.S., Inc. | 24 | $848 |
| AbbVie | 15 | $564 |
| Eisai Inc. | 21 | $376 |
| Astellas Pharma US Inc | 5 | $289 |
| Amgen | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Pfizer | 1 | $100 |
| Immunogen, Inc. | 3 | $63 |
| Novo Nordisk | 2 | $34 |
| Verastem, Inc. | 1 | $28 |
| Pharmaand GmbH | 2 | $28 |
| Mirati Therapeutics, Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $17 |
| Clovis Oncology, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,538 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $190 |
| Gabapentin | 20 | $156 |
| Ondansetron Hcl | 31 | $105 |
| Ibuprofen | 21 | $42 |
| Tramadol Hcl | 18 | $27 |
Paid to pharmacies, not to this prescriber.
Other family in Louisville
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Shelley WaldmanLouisville$59K
- Esther MuhsLouisville$44K
- Barbra CaveLouisville$41K
- Kayla WilsonLouisville$40K
- Christin ThompsonLouisville$38K
- Wendi HallerLouisville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.